The mechanisms of antibiotic resistance in major pathogens of purulent-inflammatory complications in cancer patients

The problem of microbial antibiotic resistance and investigation of its underlying mechanisms is of paramount importance for all fields of clinical medicine, including oncology. The aim of the study was to examine the mechanisms of antibiotic resistance for major pathogens causing purulent-inflammat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: O. Е. Khokhlova, I. A. Larionova, O. V. Perianova, R. S. Kozlov, M. V. Eidelshtein, A. A. Modestov, O. G. Eremeeva, I. V. Lazareva, D. N. Akusheva, T. I. Lobova, N. K. Potkina, S. V. Sidorenko, T Yamamoto
Formato: article
Lenguaje:RU
Publicado: Sankt-Peterburg : NIIÈM imeni Pastera 2021
Materias:
Acceso en línea:https://doaj.org/article/bf04d36cb47c4c468cafc70552e6dee8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bf04d36cb47c4c468cafc70552e6dee8
record_format dspace
institution DOAJ
collection DOAJ
language RU
topic multi-resistance strains
molecular genetic mechanisms
cancer patients
purulent-inflammatory complications
Infectious and parasitic diseases
RC109-216
spellingShingle multi-resistance strains
molecular genetic mechanisms
cancer patients
purulent-inflammatory complications
Infectious and parasitic diseases
RC109-216
O. Е. Khokhlova
I. A. Larionova
O. V. Perianova
R. S. Kozlov
M. V. Eidelshtein
A. A. Modestov
O. G. Eremeeva
I. V. Lazareva
D. N. Akusheva
T. I. Lobova
N. K. Potkina
S. V. Sidorenko
T Yamamoto
The mechanisms of antibiotic resistance in major pathogens of purulent-inflammatory complications in cancer patients
description The problem of microbial antibiotic resistance and investigation of its underlying mechanisms is of paramount importance for all fields of clinical medicine, including oncology. The aim of the study was to examine the mechanisms of antibiotic resistance for major pathogens causing purulent-inflammatory complications in cancer patients. Materials and methods. In 2012—2015 there was conducted a prospective examination of 184 cancer patients, including 67 patients at the Department of Surgery no. 1 and 117 patients at the Intensive Care Unit of the Krasnoyarsk Regional Clinical Oncology Center named after A.I. Kryzhanovsky. For this, we collected bronchoalveolar lavage fluid, wound discharge and investigated the material by using bacteriological method, as well as MALDI-TOF. Antibiotic sensitivity was studied as follows: disco-diffusion, double disc method, carbapenem inactivation method, staphylococcal sensitivity — by screening method, PCR, E-test method, and serial dilutions in Muller-Hinton broth. Genotyping and antibiotic resistance mechanisms study were performed by using PCR, M-PCR, and sequencing. The WHONET program (WHO) was used, with significance level set at p < 0.05. Results. Microbiological examination of bronchoalveolar lavage fluid and wound discharge samples allowed to uncover prevalent associations of multi-resistant (MDR) and extremely resistant pathogens (XDR). The microflora of the lower respiratory tract and in the wound secretion in cancer patients were found to be dominated by non-fermenting Gram-negative bacteria reaching up to 44.5% and 48%, respectively; as well as order Enterobacteriales found in 24% and 34.9%, respectively; Gram-positive bacteria — 24% and 17.1%, respectively. Imipenem- and/or meropenem-resistant P. aeruginosa and A. baumannii, K. pneumoniae strains, were assessed for MBL production phenotypically, as well as the genes of the most common VIM, IMP types, whereas A. baumannii — for OXA-23, OXA-40, and OXA-58; and K. pneumoniae — for OXA-48. 20 strains and 16 strains of P. aeruginosa and A. baumannii, respectively, were studied by PCR. It was found that A. baumannii strains formed no MBL, but 56.3% of A. baumannii isolates (9 strains) produced OXA-23 and OXA-40 carbapenemases. Among P. aeruginosa strains there were three of them which possessed VIM (15.0%), whereas the remaining strains formed no MBL, but were resistant to carbapenems being associated with other resistance mechanisms, e.g. efflux, decreased permeability of cell wall etc. Among 6 isolates of K. pneumoniae, 1 strain produced OXA-48. In cancer patients, the percentage of methicillin-resistant strains among all members of the genus Staphylococcus was 48.9% (4 strains belonged to MRSA). PVL- MRSA strains belonged to the clones ST239/spa3(t037)/SCCmecIIIA/tst,sek,seq+ (75%) and ST8/ spa1(t008)/SCCmecIVc/sea+ (25%). MRSA ST239 showed multiple antibiotic resistance: to aminoglycosides (aacA-aphD, aadD genes were detected), linkcosamides/macrolides (the ermA gene was detected), fluoroquinolones (mutations in the GyrA gene — Ser84Leu; in GrlA- Ser80Phe), rifampicin (MIC more than 128 gg/ml; mutations in the rpoB gene are His481Asn, Ile527Met), sulfamethoxazole, tetracycline (tetM gene), and chloramphenicol (66.7% of isolates, the cat gene encoding chloramphenicol acetyl transferase was detected); but sensitive to vancomycin (MIC 1.0 gg/ ml), linezolid in 100% of cases. MRSA ST8 are resistant to aminoglycosides (aacA-aphD, aadD genes), lincosamides/macrolides (ermC gene), tetracyclines (tetK gene), chloramphenicol (cat gene); and 100% sensitive to fluoroquinolones, rifampicin (MIC 0.006 gg/ml), sulfamethaxazole, vancomycin (MIC 1.0 gg/ml), daptomycin (MIC 0.094 gg/ml), linezolid (MIC 0.75 gg/ml). Conclusion. Thus, it was found that members of the order Enterobacteriales, A. baumannii, P. aeruginosa and MRSA retain high resistance to a large number of antibacterial drugs of almost all classes. These data should be taken into account while choosing proper antibiotic therapy, as well as controlling spread of nosocomial infections caused by multiresistant microorganisms.
format article
author O. Е. Khokhlova
I. A. Larionova
O. V. Perianova
R. S. Kozlov
M. V. Eidelshtein
A. A. Modestov
O. G. Eremeeva
I. V. Lazareva
D. N. Akusheva
T. I. Lobova
N. K. Potkina
S. V. Sidorenko
T Yamamoto
author_facet O. Е. Khokhlova
I. A. Larionova
O. V. Perianova
R. S. Kozlov
M. V. Eidelshtein
A. A. Modestov
O. G. Eremeeva
I. V. Lazareva
D. N. Akusheva
T. I. Lobova
N. K. Potkina
S. V. Sidorenko
T Yamamoto
author_sort O. Е. Khokhlova
title The mechanisms of antibiotic resistance in major pathogens of purulent-inflammatory complications in cancer patients
title_short The mechanisms of antibiotic resistance in major pathogens of purulent-inflammatory complications in cancer patients
title_full The mechanisms of antibiotic resistance in major pathogens of purulent-inflammatory complications in cancer patients
title_fullStr The mechanisms of antibiotic resistance in major pathogens of purulent-inflammatory complications in cancer patients
title_full_unstemmed The mechanisms of antibiotic resistance in major pathogens of purulent-inflammatory complications in cancer patients
title_sort mechanisms of antibiotic resistance in major pathogens of purulent-inflammatory complications in cancer patients
publisher Sankt-Peterburg : NIIÈM imeni Pastera
publishDate 2021
url https://doaj.org/article/bf04d36cb47c4c468cafc70552e6dee8
work_keys_str_mv AT oekhokhlova themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT ialarionova themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT ovperianova themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT rskozlov themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT mveidelshtein themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT aamodestov themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT ogeremeeva themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT ivlazareva themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT dnakusheva themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT tilobova themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT nkpotkina themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT svsidorenko themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT tyamamoto themechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT oekhokhlova mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT ialarionova mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT ovperianova mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT rskozlov mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT mveidelshtein mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT aamodestov mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT ogeremeeva mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT ivlazareva mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT dnakusheva mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT tilobova mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT nkpotkina mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT svsidorenko mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
AT tyamamoto mechanismsofantibioticresistanceinmajorpathogensofpurulentinflammatorycomplicationsincancerpatients
_version_ 1718417941786001408
spelling oai:doaj.org-article:bf04d36cb47c4c468cafc70552e6dee82021-11-22T07:09:54ZThe mechanisms of antibiotic resistance in major pathogens of purulent-inflammatory complications in cancer patients2220-76192313-739810.15789/2220-7619-TMO-1379https://doaj.org/article/bf04d36cb47c4c468cafc70552e6dee82021-03-01T00:00:00Zhttps://www.iimmun.ru/iimm/article/view/1379https://doaj.org/toc/2220-7619https://doaj.org/toc/2313-7398The problem of microbial antibiotic resistance and investigation of its underlying mechanisms is of paramount importance for all fields of clinical medicine, including oncology. The aim of the study was to examine the mechanisms of antibiotic resistance for major pathogens causing purulent-inflammatory complications in cancer patients. Materials and methods. In 2012—2015 there was conducted a prospective examination of 184 cancer patients, including 67 patients at the Department of Surgery no. 1 and 117 patients at the Intensive Care Unit of the Krasnoyarsk Regional Clinical Oncology Center named after A.I. Kryzhanovsky. For this, we collected bronchoalveolar lavage fluid, wound discharge and investigated the material by using bacteriological method, as well as MALDI-TOF. Antibiotic sensitivity was studied as follows: disco-diffusion, double disc method, carbapenem inactivation method, staphylococcal sensitivity — by screening method, PCR, E-test method, and serial dilutions in Muller-Hinton broth. Genotyping and antibiotic resistance mechanisms study were performed by using PCR, M-PCR, and sequencing. The WHONET program (WHO) was used, with significance level set at p < 0.05. Results. Microbiological examination of bronchoalveolar lavage fluid and wound discharge samples allowed to uncover prevalent associations of multi-resistant (MDR) and extremely resistant pathogens (XDR). The microflora of the lower respiratory tract and in the wound secretion in cancer patients were found to be dominated by non-fermenting Gram-negative bacteria reaching up to 44.5% and 48%, respectively; as well as order Enterobacteriales found in 24% and 34.9%, respectively; Gram-positive bacteria — 24% and 17.1%, respectively. Imipenem- and/or meropenem-resistant P. aeruginosa and A. baumannii, K. pneumoniae strains, were assessed for MBL production phenotypically, as well as the genes of the most common VIM, IMP types, whereas A. baumannii — for OXA-23, OXA-40, and OXA-58; and K. pneumoniae — for OXA-48. 20 strains and 16 strains of P. aeruginosa and A. baumannii, respectively, were studied by PCR. It was found that A. baumannii strains formed no MBL, but 56.3% of A. baumannii isolates (9 strains) produced OXA-23 and OXA-40 carbapenemases. Among P. aeruginosa strains there were three of them which possessed VIM (15.0%), whereas the remaining strains formed no MBL, but were resistant to carbapenems being associated with other resistance mechanisms, e.g. efflux, decreased permeability of cell wall etc. Among 6 isolates of K. pneumoniae, 1 strain produced OXA-48. In cancer patients, the percentage of methicillin-resistant strains among all members of the genus Staphylococcus was 48.9% (4 strains belonged to MRSA). PVL- MRSA strains belonged to the clones ST239/spa3(t037)/SCCmecIIIA/tst,sek,seq+ (75%) and ST8/ spa1(t008)/SCCmecIVc/sea+ (25%). MRSA ST239 showed multiple antibiotic resistance: to aminoglycosides (aacA-aphD, aadD genes were detected), linkcosamides/macrolides (the ermA gene was detected), fluoroquinolones (mutations in the GyrA gene — Ser84Leu; in GrlA- Ser80Phe), rifampicin (MIC more than 128 gg/ml; mutations in the rpoB gene are His481Asn, Ile527Met), sulfamethoxazole, tetracycline (tetM gene), and chloramphenicol (66.7% of isolates, the cat gene encoding chloramphenicol acetyl transferase was detected); but sensitive to vancomycin (MIC 1.0 gg/ ml), linezolid in 100% of cases. MRSA ST8 are resistant to aminoglycosides (aacA-aphD, aadD genes), lincosamides/macrolides (ermC gene), tetracyclines (tetK gene), chloramphenicol (cat gene); and 100% sensitive to fluoroquinolones, rifampicin (MIC 0.006 gg/ml), sulfamethaxazole, vancomycin (MIC 1.0 gg/ml), daptomycin (MIC 0.094 gg/ml), linezolid (MIC 0.75 gg/ml). Conclusion. Thus, it was found that members of the order Enterobacteriales, A. baumannii, P. aeruginosa and MRSA retain high resistance to a large number of antibacterial drugs of almost all classes. These data should be taken into account while choosing proper antibiotic therapy, as well as controlling spread of nosocomial infections caused by multiresistant microorganisms.O. Е. KhokhlovaI. A. LarionovaO. V. PerianovaR. S. KozlovM. V. EidelshteinA. A. ModestovO. G. EremeevaI. V. LazarevaD. N. AkushevaT. I. LobovaN. K. PotkinaS. V. SidorenkoT YamamotoSankt-Peterburg : NIIÈM imeni Pasteraarticlemulti-resistance strainsmolecular genetic mechanismscancer patientspurulent-inflammatory complicationsInfectious and parasitic diseasesRC109-216RUInfekciâ i Immunitet, Vol 11, Iss 2, Pp 324-336 (2021)